COVID 19 Impact on Indonesia Clinical Lab Market: Ken Research

How The Indonesia Clinical Lab Market Is Positioned?

Indonesia Clinical Lab market was observed to grow with an augmenting growth rate in the review period 2016-2021. The Indonesia Clinical Lab market in terms of Revenue has increased at a positive CAGR of ~% during the review period 2016-2021. The growth was supported by increase in healthcare spending by aging population, expanding health insurance, growth in non-communicable disease and chronic diseases, rising disposable Income. The market for clinical labs in Indonesia is highly fragmented among the top players.

While talking in terms of region, Greater Jakarta and Java, Bali and Nusa contribute more than half of the revenue share. There are about ~ organized players in the market who also dominate the overall market in terms of revenue. The market is dominated by public hospital labs. The overall focus accreditation is low in the market especially in the unorganized sector.

Around 70% of medical decisions regarding early disease diagnosis, patient prognosis and treatment selection are based on laboratory diagnostic results. Along with treatment regime selection, diagnostic test results help in monitoring of the patient condition during recovery and follow-up.Indonesia Clinical Lab Market

With these multiple touchpoints, laboratory tests contribute 80% of the objective data in clinical records. In modern medicine, with data analytics and AI taking center stage, these clinical records will help in predictive analysis and disease prevention going forward.

Indonesia Clinical Lab Market Segmentation

By Type of Labs: Clinical Laboratories can be recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs. Public Hospital Labs have a majority in the Indonesian market followed by Private Hospital Labs.

By Number of Labs: The labs can be recognized as public or private labs basis their ownership. Private Labs dominate the market in Indonesia.

Click Here for Sample Report: –

By Type of Private Independent Labs: Basis this segmentation, laboratories can be recognized as organized and unorganized labs. Organized labs being those which have more than 3 branches in the region versus unorganized labs who have 3 or less than 3 labs in the region. In Indonesia, organized labs dominate the market with a market share of ~% followed by unorganized labs with a share of ~%.

By Type of Payor: Corporates have accounted for the largest share of ~% of the number of tests in Indonesia. As the growing Indonesian workforce has led to an increase in corporate clients for pre-employment checks and annual health checks. More companies are engaging with private medical labs.

By Type of Consumer (Basis Number of Tests): Majority of the patients who are consumer to these laboratories come through doctor referrals with a market share of ~% based on the number of tests. This is followed by walk-ins and corporate clients with a market share of ~% and ~% respectively.

By Type of Tests: On the basis of type of tests the market is split between Routine, Esoteric and Non-laboratory tests. The most popular in the market are Routine tests with a market share of ~%. The non-laboratory tests account for a relatively small share of lab tests due to the additional licenses required to carry them out. Thus, laboratories are reluctant to do those tests.

By Type of Routine Tests: The routine tests have different categories of tests. The leader in this category is CBC followed by Basic Metabolic Panel.

By Esoteric tests: The esoteric tests have different categories of tests. The leader in this category is endocrine followed by infectious disease.

By Region: Java, Jakarta and Bali have high rate of urbanization and more affluent population, which has created greater access and demand for private clinical laboratory testing services.

By Private Hospital Labs: Private hospitals either have their own in-house labs or have a tie-up with a third-party lab to accommodate their labs. In Indonesia in-house laboratories have a greater share.

What is the competition scenario in the Indonesia clinical lab market?

Market is dominated by Prodia (PRDA), contributing more than ~% of the market share by revenue with ¬ outlets across 127 cities and 34 provinces in Indonesia which makes PRDA as a market leader. Kimia farma is the 2nd major player with ¬% market share and Bio medika is the least contributor i.e., ¬%. CITO contributed ¬% of market share and was designated by the Ministry of Health to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market. To capture the shift, industry leaders have started to implement initiatives such as retailer partnering, offering home testing, and enhancing engagement with patients through digital presence.

Company Profile Of Major Players Operating In Indonesia Clinical Lab Market (Case Study)

Prodia: PRDA applies the hub and spoke business model, which currently has 4 hubs in Jakarta, Medan, Surabaya and Makassar, while the number of spokes owned is around 148 branches. Spokes/branches carry out 300-400 types of routine tests, while at the hubs, they carry out 800-850 types of tests, both routine & esoteric tests.

Diagnos: The Company realizes that currently it is still very necessary to deploy a Laboratory Network, both as a health facility in a hospital, independent branches and outlets

Indonesia Clinical Lab Market Future Outlook and Projections

Over the forecast period 2022-2026F, the Indonesia Clinical Lab Market Revenue is further anticipated to increase to USD ~ Million by the year 2026F, thus showcasing a CAGR of ~%. It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Players, investing to increase its testing capabilities and has adopted several advanced tests and technologies introduced in the global market, particularly specialized tests. Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market.

For More Information on the Research Report, refer to below links: –

Indonesia Clinical Laboratory Market

Related Reports by Ken Research: –

Vietnam Clinical Laboratory Market Outlook to 2022 – by Labs (Hospital Labs, Independent Labs and Physician Office Labs) and Type of Tests (Lab Test, X-Ray, Ultrasound and CT Scan)

Indonesia Clinical Laboratory Market Outlook to 2022 – By Type (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), By Type of Test (Routine, Non Laboratory and Esoteric)

Contact Us: –

Ken Research

Ankur Gupta, Head Marketing & Communications


Follow Us

LinkedIn | Instagram | Facebook | Twitter | YouTube

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

scroll to top